37
Participants
Start Date
November 30, 2006
Primary Completion Date
February 28, 2011
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Given IV
Laboratory Biomarker Analysis
Correlative studies
Women's Cancer Care Associates LLC, Albany
Abington Memorial Hospital, Abington
Carilion Clinic Gynecological Oncology, Roanoke
University of North Carolina, Chapel Hill
Lake University Ireland Cancer Center, Mentor
Cleveland Clinic Foundation, Cleveland
Iowa Methodist Medical Center, Des Moines
Iowa Oncology Research Association CCOP, Des Moines
Medical Oncology and Hematology Associates-Des Moines, Des Moines
Medical Oncology and Hematology Associates-Laurel, Des Moines
Mercy Medical Center - Des Moines, Des Moines
Iowa Lutheran Hospital, Des Moines
University of Wisconsin Hospital and Clinics, Madison
Saint Vincent Hospital, Green Bay
Rush University Medical Center, Chicago
Carle Clinic-Urbana Main, Urbana
Mercy Hospital Springfield, Springfield
University of Oklahoma Health Sciences Center, Oklahoma City
Tulsa Cancer Institute, Tulsa
M D Anderson Cancer Center, Houston
University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora
Women's Cancer Center of Nevada, Las Vegas
Cooper Hospital University Medical Center, Camden
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County, Mount Holly
Virtua West Jersey Hospital Voorhees, Voorhees Township
Lyndon Baines Johnson General Hospital, Houston
National Cancer Institute (NCI)
NIH
Gynecologic Oncology Group
NETWORK